Flip Therapeutics
Flip Therapeutics develops in vivo immune cell reprogramming therapies for chronic autoimmune and inflammatory diseases.
Seed ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredJul 3, 2024 (2 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | undisclosed | — | — |
Timeline
- Website created
Founders and team
DP
Dave Pajerowski Co-Founder, CEO & Head of TechnologyLinkedIn · source: fliptx.bioAG
Anis Gammage Co-Foundersource: fliptx.bioMP
Mathias Pawlak Co-Foundersource: fliptx.bio
Investors
Companies like Flip Therapeutics
NNuvigSeries A · Dec 2024MMirador Therapeutics$250M Series B+ · Jan 2026
EEngimmune Therapeutics$16M Seed · May 2022MMogrifySeries A · Oct 2023
NNilo Therapeutics$101M Series A · Oct 2025
MMozart Therapeutics$25M Series A · Jun 2023
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/flip-therapeutics (get a free API key).